Prostate-Specific Antigen (PSA) Testing: A Urologist's Perspective
Published February 5, 2019
21 min
    Add to queue
    Copy URL
    Show notes
    Prostate cancer is a very common malignancy in men, second only to skin cancer. Despite the fact that it’s one of the more treatable malignancies, it remains the 2nd leading cause of cancer death in men. When diagnosed early, it has an excellent prognosis. The 5-year survival rate approaches 100% in those with local or regional disease. Although screening for prostate cancer is available, the use of screening tests has been controversial and recommendations regarding its use, confusing. Listen in to get a urologist’s perspective.
        0:00:00 / 0:00:00